Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · Real-Time Price · USD
1.430
-0.060 (-4.03%)
At close: Mar 28, 2025, 4:00 PM
1.427
-0.003 (-0.21%)
After-hours: Mar 28, 2025, 7:15 PM EDT

Company Description

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery, clinical research, and diagnostics in North America, the Asia-Pacific, Europe, the Middle East, and Africa.

The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow.

It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI.

Akoya Biosciences, Inc. was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Akoya Biosciences, Inc.
Akoya Biosciences logo
Country United States
Founded 2015
IPO Date Apr 16, 2021
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 205
CEO Brian McKelligon

Contact Details

Address:
100 Campus Drive, 6th Floor
Marlborough, Massachusetts 01752
United States
Phone 855 896 8401
Website akoyabio.com

Stock Details

Ticker Symbol AKYA
Exchange NASDAQ
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
IPO Price $20.00
CIK Code 0001711933
CUSIP Number 00974H104
ISIN Number US00974H1041
Employer ID 47-5586242
SIC Code 3826

Key Executives

Name Position
Brian McKelligon President, Chief Executive Officer and Director
Anthony Catalano Senior Vice President of Operations
Priyam Shah Senior Director of Business Development and Investor Relations Strategy
Jennifer Kamocsay Chief Legal Officer
Dr. Niro Ramachandran Ph.D. Chief Business Officer
Dr. Pascal Bamford Ph.D. Senior Vice President of Research and Development and Laboratory Operations
Rob C. Hart C.F.A., CFA, J.D. Secretary

Latest SEC Filings

Date Type Title
Mar 18, 2025 425 Filing
Mar 17, 2025 425 Filing
Mar 17, 2025 10-K Annual Report
Mar 17, 2025 S-8 Securities to be offered to employees in employee benefit plans
Mar 17, 2025 8-K Current Report
Mar 3, 2025 425 Filing
Feb 25, 2025 425 Filing
Feb 25, 2025 425 Filing
Feb 25, 2025 8-K Current Report
Feb 11, 2025 425 Filing